Cargando…

Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Fibroblast growth factor receptor (FGFR) gene amplification has been reported in different types of cancer. We performed an up-to-date meta-analysis to further characterize the prognostic value of FGFR gene amplification in patients with cancer. METHODS: A search of several databases, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jinjia, Liu, Xinyang, Wang, Shanshan, Zhang, Zhe, Wu, Zheng, Zhang, Xiaowei, Li, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149366/ https://www.ncbi.nlm.nih.gov/pubmed/25171497 http://dx.doi.org/10.1371/journal.pone.0105524

Ejemplares similares

Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis
por: Hu, Yao, et al.
Publicado: (2021)

Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer
por: Chang, Jinjia, et al.
Publicado: (2014)

MUC1 gene polymorphism rs4072037 and susceptibility to gastric cancer: a meta-analysis
por: Liu, Xinyang, et al.
Publicado: (2014)

Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review
por: Kim, Hyeong Su, et al.
Publicado: (2019)

FGFR2 amplification in colorectal adenocarcinoma
por: Carter, Jamal H., et al.
Publicado: (2017)

MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer
por: Liu, Xinyang, et al.
Publicado: (2015)

The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
por: Zhang, Wenjing, et al.
Publicado: (2020)

Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis
por: Zhao, Haiyue, et al.
Publicado: (2018)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
por: Hyung, Sujin, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer
por: Yang, Chengcheng, et al.
Publicado: (2022)

FGFR2 gene amplification and clinicopathological features in gastric cancer
por: Matsumoto, K, et al.
Publicado: (2012)

The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data
por: Wang, Yang, et al.
Publicado: (2015)

The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis
por: Xie, Fa-Jun, et al.
Publicado: (2016)

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017)

FGFR1 amplification and the progression of non-invasive to invasive breast cancer
por: Gru, Alejandro A, et al.
Publicado: (2012)

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
por: Su, X, et al.
Publicado: (2014)

Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
por: Zhu, Zhenhua, et al.
Publicado: (2017)

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
por: Elbauomy Elsheikh, Somaia, et al.
Publicado: (2007)

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
por: Brunello, Eleonora, et al.
Publicado: (2012)

FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro
por: Cha, Yongjun, et al.
Publicado: (2018)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients
por: Sevillano Fernández, Elena, et al.
Publicado: (2022)

Incidence and prognostic value of pulmonary embolism in COVID-19: A systematic review and meta-analysis
por: Gong, Xiaowei, et al.
Publicado: (2022)

The use of DNA repair genes as prognostic indicators of gastric cancer
por: Jinjia, Chang, et al.
Publicado: (2019)

Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
por: Jogo, Tomoko, et al.
Publicado: (2021)

Metabolic syndrome and esophageal cancer risk: a systematic review and meta‑analysis
por: Zhang, Jinjia, et al.
Publicado: (2021)

Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis
por: Jiang, Lin, et al.
Publicado: (2022)

Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis
por: Kim, Hyeong Su, et al.
Publicado: (2019)

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
por: Dutt, Amit, et al.
Publicado: (2011)

Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis
por: Hammam, Olfat, et al.
Publicado: (2017)

Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer
por: Minashi, Keiko, et al.
Publicado: (2021)

Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer
por: Mohan, Prathibha, et al.
Publicado: (2022)

Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer
por: Dai, Congqi, et al.
Publicado: (2016)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021)

Prognostic Value of LGR5 in Colorectal Cancer: A Meta-Analysis
por: Chen, Qing, et al.
Publicado: (2014)

The Relationship Between Fibroblastic Growth Factor Receptor-1 (FGFR1) Gene Amplification in Triple Negative Breast Carcinomas and Clinicopathological Prognostic Factors
por: Jafarian, Amir Hossein, et al.
Publicado: (2019)

Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2020)

Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis
por: Jiang, Tao, et al.
Publicado: (2015)

The Combination of RAD001 and MK-2206 Exerts Synergistic Cytotoxic Effects against PTEN Mutant Gastric Cancer Cells: Involvement of MAPK-Dependent Autophagic, but Not Apoptotic Cell Death Pathway
por: Ji, Dongmei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_070ceq4e7sujtchup3da75p9gg